{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:27:26Z","timestamp":1773044846936,"version":"3.50.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/mbc.0b013e32832da121","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T18:49:57Z","timestamp":1250189397000},"page":"461-465","source":"Crossref","is-referenced-by-count":8,"title":["Postpartum-acquired haemophilia A: a description of three cases and literature review"],"prefix":"10.1097","volume":"20","author":[{"given":"Rita C","family":"Santoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Prejan\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajh.20702","article-title":"Postpartum acquired factor VIII inhibitors","volume":"81","author":"Franchini","year":"2006","journal-title":"Am J Hematol"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.1987.00370060073014","article-title":"Acquired haemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy","volume":"147","author":"Lottemberg","year":"1987","journal-title":"Arch Intern Med"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 nonhemophilic patients with inhibitors to factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: a concise review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am J Hematol"},{"key":"R5-14-20210203","first-page":"311","article-title":"Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Registrer relevant to clinical practise","volume":"110","author":"Baudo","year":"2003","journal-title":"Int J Obstet Gynecol"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1651666","article-title":"Postpartum factor VIII inhibitors. A review of the literature with special reference to the value of the steroid and immunosuppressive treatment","volume":"73","author":"Hauser","year":"1995","journal-title":"Thromb Haemost"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9343(98)00289-7","article-title":"Acquired hemophilia due to factor VIII inhibitors in 34 patients","volume":"105","author":"Bossi","year":"1998","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"R8-14-20210203","first-page":"16","article-title":"Treatment of acquired hemophilia","volume":"31","author":"Ludlam","year":"1994","journal-title":"Semin Hematol"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1995.tb03294.x","article-title":"Acquired haemophilia and its treatment","volume":"89","author":"Morrison","year":"1995","journal-title":"Br J Haematol"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V58.3.619.619","article-title":"Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis","volume":"58","author":"Coller","year":"1981","journal-title":"Blood"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(91)80139-D","article-title":"An introduction to factor VIII inhibitors: the detection and quantitation","volume":"91","author":"Kessler","year":"1991","journal-title":"Am J Med"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V74.5.1618.1618","article-title":"Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization","volume":"74","author":"Scandella","year":"1989","journal-title":"Blood"},{"key":"R13-14-20210203","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1182\/blood.V89.10.3663","article-title":"The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies","volume":"89","author":"Prescott","year":"1997","journal-title":"Blood"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br J Haematol"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/107602960000600206","article-title":"Acquired hemophilia in women postpartum: clinical manifestations, diagnosis and treatment","volume":"6","author":"Michiels","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"R16-14-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<1::AID-AJH1>3.0.CO;2-T","article-title":"Postpartum acquired factor VIII inhibitors: results of a survey","volume":"59","author":"Solymoss","year":"1998","journal-title":"Am J Hematol"},{"key":"R17-14-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(02)00027-1","article-title":"Acquired factor VIII inhibitors as a cause of primary post-partum haemorrhage","volume":"103","author":"Howland","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2002-03-0765","article-title":"Rituximab in the treatment of acquired factor VIII inhibitors","volume":"100","author":"Wiestner","year":"2002","journal-title":"Blood"},{"key":"R19-14-20210203","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7326\/0003-4819-127-3-199708010-00005","article-title":"Successful treatment of acquired hemophilia with oral immunosuppressive therapy","volume":"127","author":"Schaffer","year":"1997","journal-title":"Ann Intern Med"},{"key":"R20-14-20210203","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1538-7836.2007.02433.x","article-title":"Treatment of acquired hemophilia A","volume":"5","author":"Collins","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R21-14-20210203","first-page":"221","article-title":"Inhibitor to factor VIII in a nonhaemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII","volume":"29","author":"Chistolini","year":"1987","journal-title":"Neuve Revue Francaise Haematologie"},{"key":"R22-14-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.2830430413","article-title":"DDAVP in acquired haemophilia A: case report and review of the literature","volume":"43","author":"Mudad","year":"1993","journal-title":"Am J Haemtol"},{"key":"R23-14-20210203","first-page":"1054","article-title":"A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the successful treatment of acquired hemophilia A with high-titer inhibitor","volume":"84","author":"Gandini","year":"1999","journal-title":"Haematologica"},{"key":"R24-14-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-0038-1650216","article-title":"Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia A and inhibitors: the results of an international survey","volume":"75","author":"Hay","year":"1996","journal-title":"Thromb Haemost"},{"key":"R25-14-20210203","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.V81.6.1513.1513","article-title":"Use of porcine factor VIII in the treatment of patients with acquired hemophilia","volume":"81","author":"Morrison","year":"1993","journal-title":"Blood"},{"issue":"Suppl 5","key":"R26-14-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2516.2006.01383.x","article-title":"The management of acquired haemophilia","volume":"12","author":"Green","year":"2006","journal-title":"Haemophilia"},{"key":"R27-14-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2516.2003.00856.x","article-title":"Treatment of acquired hemophilia with factor eight inhibitor bypassing activity","volume":"10","author":"Sallah","year":"2004","journal-title":"Haemophilia"},{"key":"R28-14-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2516.2002.00532.x","article-title":"Safety of factor VIII inhibitors bypass activity (FEIBA): 10 year compilation of thrombotic adverse events","volume":"8","author":"Ehrlich","year":"2002","journal-title":"Haemophilia"},{"key":"R29-14-20210203","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00134-002-1469-1","article-title":"NovoSeven: mode of action and use in acquired haemophilia","volume":"28","author":"Von Depka","year":"2002","journal-title":"Intensive Care Med"},{"key":"R30-14-20210203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2516.2007.01474.x","article-title":"Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal","volume":"13","author":"Sumner","year":"2007","journal-title":"Haemophilia"},{"issue":"Suppl 3","key":"R31-14-20210203","first-page":"014","article-title":"Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: the French experience [abstract]","volume":"10","author":"Goudemand","year":"2004","journal-title":"Haemophilia"},{"key":"R32-14-20210203","first-page":"3","article-title":"The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicenter study","volume":"78","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"R33-14-20210203","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"R34-14-20210203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R35-14-20210203","first-page":"759","article-title":"Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian Registry of acquired hemophilia","volume":"89","author":"Baudo","year":"2004","journal-title":"Haematologica"},{"key":"R36-14-20210203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2000.02327.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctor's Organization (UKHCDO)","volume":"111","author":"Hay","year":"2000","journal-title":"Br J Haematol"},{"key":"R37-14-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1471-0528.2003.01535.x","article-title":"Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practise","volume":"110","author":"Baudo","year":"2003","journal-title":"BJOG"},{"key":"R38-14-20210203","first-page":"895","article-title":"Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies","volume":"85","author":"Petrovic","year":"2000","journal-title":"Haematologica"},{"key":"R39-14-20210203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-110-10-774","article-title":"Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor","volume":"110","author":"Liam","year":"1989","journal-title":"Ann Intern Med"},{"key":"R40-14-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0609.1997.tb00733.x","article-title":"Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor","volume":"59","author":"Michiels","year":"1997","journal-title":"Eur J Haematol"},{"key":"R41-14-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V86.2.797.bloodjournal862797","article-title":"A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin","volume":"86","author":"Schwartz","year":"1995","journal-title":"Blood"},{"key":"R42-14-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2516.2001.00489.x","article-title":"Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review","volume":"7","author":"Dykes","year":"2001","journal-title":"Haemophilia"},{"key":"R43-14-20210203","first-page":"422","article-title":"Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone","volume":"7","author":"Mazzucconi","year":"2001","journal-title":"Haemophilia"},{"key":"R44-14-20210203","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"Ann Oncol"},{"key":"R45-14-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH06-06-0317","article-title":"The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders","volume":"96","author":"Franchini","year":"2006","journal-title":"Thromb Haemost"},{"key":"R46-14-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2006.11.004","article-title":"Rituximab in the treatment of adult acquired hemophilia A: a systematic review","volume":"63","author":"Franchini","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"R47-14-20210203","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2003-11-4075","article-title":"Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia","volume":"103","author":"Stasi","year":"2004","journal-title":"Blood"},{"key":"R48-14-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","article-title":"Rituximab in the treatment of autoimmune haematological disorders","volume":"141","author":"Garvey","year":"2008","journal-title":"Br J Haematol"},{"key":"R49-14-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2516.2005.01060.x","article-title":"Rituximab for autoimmune haemophilia: a proposed treatment algorithm","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Haemophilia"},{"key":"R50-14-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2516.2007.01587.x","article-title":"Efficacy of rituximab treatment in postpartum acquired haemophilia A","volume":"14","author":"Santoro","year":"2008","journal-title":"Haemophilia"},{"key":"R51-14-20210203","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation","volume":"133","author":"Hay","year":"2006","journal-title":"Br J Haematol"},{"key":"R52-14-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors","volume":"112","author":"Franchini","year":"2008","journal-title":"Blood"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200909000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T21:28:53Z","timestamp":1710538133000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200909000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832da121","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}